-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0215_01-06-2010.pdf
January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed
in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND__0355_09-22-2010.pdf
January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in
the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in
phase … Results
The table below lists the seven topics for which (1) preliminary phase III data on drugs or … Mifepristone for treating PMD is being investigated in one phase III clinical trial. … Three
phase III trials did not individually demonstrate statistical superiority of mifepristone over … Paul, MN) are both in phase III development for DBS for
MDD.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Results
The table below lists the 17 topics for which (1) preliminary phase III data were available … In phase III trials, icatibant provided significant symptom relief within about 2
hours and initial … Placebo-
controlled phase 3 study of oral BG-12 for
relapsing multiple sclerosis. … Placebo-
controlled phase 3 study of oral BG-12 or
glatiramer in multiple sclerosis. … ThromboGenics'
microplasmin phase III program progressing
according to schedule. [internet].
-
effectivehealthcare-admin.ahrq.gov/products/distributed-network-expansion/research
January 01, 2019 - The enhancements described below will be incorporated into Phase 2 of our Distributed Research Network … We designated this activity as Phase 1.5, to distinguish it from the task order that ended in August … Our approach was based on lessons learned from Phase 1 of DRN and specifically on our findings that a … Data Mart Client Functions
Workflow Manager— In this phase, the Data Mart Client was extended so … Document Scope
This document describes the functional requirements and design for DRN phase 1.5.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - Results
The table below lists the five topics for which (1) preliminary phase III data for drugs were … Completed phase III trials did not demonstrate statistical superiority
of mifepristone over placebo … Paul, MN) are in phase III development for DBS for
treating BPD and MDD. … Reclaim/Activa trials for MDD have an anticipated completion date
of October 2014; phase III trials … III clinical
trial.9 Three completed phase III trials did not demonstrate superiority of mifepristone
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ptsd-comments.pdf
November 04, 2020 - Since the Phase 1 work and report,
we have worked closely with the National
Center for PTSD to obtain … Since the Phase 1 work and report,
we have worked closely with the National
Center for PTSD to obtain … For this phase of development, as
recommended by the TEP and NCPTSD,
treatments were categorized according … of the PTSD-Repository and
updated in this next phase of work. … in a subsequent
article highlighting the updates to the PTSD-
Repository completed in this second phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … None of these topics
emerged as eligible for inclusion in this report because preliminary phase III … These topics were ineligible for
consideration in this report because no phase III data were available
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
January 01, 2012 - Results
The table below lists the 12 topics for which (1) preliminary phase III data on drugs or phase … Mifepristone for treating PMD is being investigated in one phase III clinical trial. … Reclaim is in phase III trials for MDD with an anticipated
completion date of October 2014; Libra is … also in phase III trials. … Jude Medical is evaluating its Libra
®
DBS system for treatment-resistant depression in the
phase
-
effectivehealthcare-admin.ahrq.gov/products/chronic-urinary-retention/research-protocol
December 01, 2020 - During the Topic Refinement phase of this project, Key Informants suggested that a review focused on … Key Questions
The draft Key Questions (KQs) developed during the Topic Refinement phase were posted … Blind Method/ (118498)
Single Blind Method/ (17086)
clinical trial/ (476450)
clinical trial, phase … i.pt. (12809)
clinical trial, phase ii.pt. (20505)
clinical trial, phase iii.pt. (7571)
clinical … trial, phase iv.pt. (759)
controlled clinical trial.pt. (85694)
randomized controlled trial.pt.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - versus active
surveillance in men with low-risk
prostate cancer (CLIN1001 PCM301):
an open-label, phase … Patients With Low-
Risk Prostate Cancer Treated With
Hypofractionated vs Conventional
Radiotherapy: A Phase … 26 (763246)
29 27 and 28 (43063)
30 limit 29 to (clinical trial, all or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase
iii or clinical trial, phase iv or clinical
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies/protocol
March 01, 2020 - therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase … Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase … 26 (763246)
29 27 and 28 (43063)
30 limit 29 to (clinical trial, all or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase iii or clinical trial, phase iv or clinical trial
-
effectivehealthcare-admin.ahrq.gov/products/tethered-spinal-cord/protocol
August 01, 2023 - Lipomyelomeningocele" OR "tight filum syndrome"
Recruitment: Completed studies
Study Results: All studies
Phase … : Phase 2, Phase 3, Phase 4
ICTRP
No limits
“tethered cord syndrome” OR “tethered spinal cord” … lying spinal cord” OR “filum terminale syndrome OR Lipomyelomeningocele” OR “tight filum syndrome”
Phase … : Phase 2, Phase 3, Phase 4
Cochrane Database of Systematic Reviews
tethered cord syndrome OR tethered
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tethered-spinal-cord-protocol.pdf
July 19, 2023 - Lipomyelomeningocele" OR "tight filum syndrome"
Recruitment: Completed studies
Study Results: All studies
Phase … : Phase 2, Phase 3, Phase 4
ICTRP
No limits
“tethered cord syndrome” OR “tethered spinal cord … lying spinal cord” OR “filum
terminale syndrome OR Lipomyelomeningocele” OR “tight filum syndrome”
Phase … : Phase 2, Phase 3, Phase 4
Cochrane Database of Systematic Reviews
tethered cord syndrome OR tethered
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
June 01, 2013 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in
phase … Results
The table below lists three topics in the system for which (1) preliminary phase III or later … Several phase III trials have been
cosponsored by the Cystic Fibrosis Foundation, of Bethesda, MD. … In a
randomized, double-blind, placebo-controlled, phase III trial, cosponsored by the Cystic Fibrosis … Vertex Pharmaceuticals initiates phase 3 registration
program for VX-770, an oral CFTR potentiator
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
April 01, 2012 - III trials
for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … The table below lists the three topics for which (1) preliminary phase III were
available for drugs … , or phase II, III or later data were available for devices; (2) information was
compiled by November … The drug is in several phase III clinical trials cosponsored
by the Cystic Fibrosis Foundation. … Vertex Pharmaceuticals initiates phase 3
registration program for VX-770, an oral CFTR
potentiator
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
April 01, 2016 - therapy [CBT or interpersonal therapy [IPT]]) differ in efficacy or effectiveness in
treating acute phase … treatments compare with pharmacological
treatments in efficacy or effectiveness in treating acute-phase … Current Literature Analysis:
• We identified a small phase II RCT examining individuals with MDD who … Tier 3:
A small phase II RCT (n=60) examined
individuals with MDD who had responded to
ECT and … RESULTS: Of 90 MDD patients starting the acute phase, 70% responded and 47% remitted to acute ECT.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/goldstrom.pdf
January 06, 2017 - process and
inclusive of many stakeholders, there needs to be sufficient time for feedback
at each phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0653-131114.pdf
June 14, 2013 - populations, interventions, comparators, and outcomes, will
be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0263_12-28-2007.pdf
January 01, 2007 - populations,
interventions, comparators, and outcomes, will be further developed in the refinement phase